The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy

Kidney International

Volumn 86, Issue 2, 2014, Pages 259-265

  Mallipattu, Sandeep K ^a   Salem, Fadi ^b   Wyatt, Christina M ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

collapsing FSGS; hepatitis; HIV

Indexed keywords

ATAZANAVIR; INDINAVIR; LOPINAVIR; TENOFOVIR DISOPROXIL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AFRICA SOUTH OF THE SAHARA; ANTIVIRAL THERAPY; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EUROPE; FOCAL GLOMERULOSCLEROSIS; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HEPATITIS C; HIGH RISK POPULATION; HIV ASSOCIATED NEPHROPATHY; HIV RELATED CHRONIC KIDNEY DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MIXED INFECTION; NEPHROSCLEROSIS; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UNITED STATES; AIDS-ASSOCIATED NEPHROPATHY; COINFECTION; COMPLICATION; DIABETES COMPLICATIONS; HEPATITIS C, CHRONIC; RENAL INSUFFICIENCY, CHRONIC;

AFRICA SOUTH OF THE SAHARA; AIDS-ASSOCIATED NEPHROPATHY; ANTI-HIV AGENTS; COINFECTION; DIABETES COMPLICATIONS; HEPATITIS C, CHRONIC; HUMANS; HYPERTENSION; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES;

EID: 84905505802     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.44     Document Type: Short Survey

References (50)

1. Bao L, Salomon JA, Brown T et al. Modelling national HIV/AIDS epidemics: revised approach in the UNAIDS estimation and projection package 2011. Sex Transm Infect 2012; 88(Suppl 2): i3-i10.
2. Rao TK, Filippone EJ, Nicastri AD et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984; 310: 669-673.
3. United States Renal Data System (USRDS) 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. http://www.usrds.org/adr.htm 2011.
4. Ross MJ. Advances in the pathogenesis of HIV-associated kidney diseases. Kidney Int 2014 (this issue).
5. Berliner AR, Fine DM, Lucas GM et al. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol 2008; 28: 478-486.
6. Mocroft A, Kirk O, Reiss P et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS 2010; 24: 1667-1678.
7. Scherzer R, Estrella M, Li Y et al. Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS 2012; 26: 867-875.
8. Office of AIDS Research Advisory CouncilGuidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. http://aidsinfo.nih.gov/guidelines. 2013.
9. Lucas GM, Lau B, Atta MG et al. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis 2008; 197: 1548-1557.
10. Choi AI, Rodriguez RA, Bacchetti P et al. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol 2007; 18: 2968-2974.
11. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845.
12. Inker LA, Wyatt C, Creamer R et al. Performance of creatinine and cystatin c gfr estimating equations in an hiv-positive population on antiretrovirals. J Acquir Immune Defic Syndr 2012; 61: 302-309.
13. Vrouenraets SM, Fux CA, Wit FW et al. A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function. Clin Nephrol 2012; 77: 311-320.
14. Wyatt CM, Schwartz GJ, Owino Ong'or W et al. Estimating kidney function in hiv-infected adults in kenya: comparison to a direct measure of glomerular filtration rate by iohexol clearance. PloS one 2013; 8: e69601.
15. Driver TH, Scherzer R, Peralta CA et al. Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women. AIDS 2013; 27: 2291-2299.
16. Lucas G, Cozzi-Lepri A, Wyatt C et al. Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals. HIV Med 2014; 15: 116-123.
17. Lucas GM, Mehta SH, Atta MG et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 2007; 21: 2435-2443.
18. Wyatt CM, Morgello S, Katz-Malamed R et al. The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int 2009; 75: 428-434.
19. Medapalli RK, Parikh CR, Gordon K et al. Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study. J Acquir Immune Defic Syndr 2012; 60: 393-399.
20. Mallipattu SK, Liu R, Zhong Y et al. Expression of HIV transgene aggravates kidney injury in diabetic mice. Kidney Int 2013; 83: 626-634.
21. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006; 44: S6-S9.
22. Wyatt CM, Malvestutto C, Coca SG et al. The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and metaanalysis. AIDS 2008; 22: 1799-1807.
23. Tsui J, Vittinghoff E, Anastos K et al. Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study. Am J Kidney Dis 2009; 54: 43-50.
24. Fischer MJ, Wyatt CM, Gordon K et al. Hepatitis C and the risk of kidney disease and mortality in veterans with HIV. J Acquir Immune Defic Syndr 2010; 53: 222-226.
25. Mocroft A, Neuhaus J, Peters L et al. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PloS one 2012; 7: e40245.
26. Peters L, Grint D, Lundgren JD et al. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients. AIDS 2012; 26: 1917-1926.
27. Lucas GM, Jing Y, Sulkowski M et al. Hepatitis C Viremia and the Risk of Chronic Kidney Disease in HIV-Infected Individuals. J Infect Dis 2013; 208: 1240-1249.
28. Fine DM, Garg N, Haas M et al. Cocaine use and hypertensive renal changes in HIV-infected individuals. Clin J Am Soc Nephrol 2007; 2: 1125-1130.
29. Izzedine H, Sene D, Cacoub P et al. Kidney diseases in HIV/HCV-coinfected patients. AIDS 2009; 23: 1219-1226.
30. Mohan S, Herlitz LC, Tan J et al. The changing pattern of glomerular disease in HIV and hepatitis C co-infected patients in the era of HAART. Clin Nephrol 2013; 79: 285-291.
31. Cooper RD, Wiebe N, Smith N et al. Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clinical Infect Dis 2010; 51: 496-505.
32. Ryom L, Mocroft A, Kirk O et al. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. J Infect Dis 2013; 207: 1359-1369.
33. Wever K, van Agtmael MA, Carr A. Incomplete reversibility of tenofovirrelated renal toxicity in HIV-infected men. J Acquir Immune Defic Syndr 2010; 55: 78-81.
34. Wools-Kaloustian K, Gupta SK, Muloma E et al. Renal disease in an antiretroviral-naive HIV-infected outpatient population in Western Kenya. Nephrol, Dial, Transplant 2007; 22: 2208-2212.
35. Emem CP, Arogundade F, Sanusi A et al. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol, Dial, Transplant 2008; 23: 741-746.
36. Mulenga LB, Kruse G, Lakhi S et al. Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. AIDS 2008; 22: 1821-1827.
37. Lucas GM, Clarke W, Kagaayi J et al. Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda. J Acquir Immune Defic Syndr 2010; 55: 491-494.
38. Wyatt CM, Shi Q, Novak JE et al. Prevalence of kidney disease in HIVinfected and uninfected Rwandan women. PloS one 2011; 6: e18352.
39. Jao J, Lo W, Toro PL et al. Factors associated with decreased kidney function in HIV-infected adults enrolled in the MTCT-Plus Initiative in sub- Saharan Africa. J Acquir Immune Defic Syndr 2011; 57: 40-45.
40. Peters PJ, Moore DM, Mermin J et al. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int 2008; 74: 925-929.
41. Reid A, Stohr W, Walker AS et al. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis 2008; 46: 1271-1281.
42. van Deventer HE, Paiker JE, Katz IJ et al. A comparison of cystatin C- and creatinine-based prediction equations for the estimation of glomerular filtration rate in black South Africans. Nephrol, Dial, Transplant 2011; 26: 1553-1558.
43. Kopp JB, Nelson GW, Sampath K et al. APOL1 genetic variants in focal segmental glomerulosclerosis and hiv-associated nephropathy. J Am Soc Nephrol 2011; 22: 2129-2137.
44. Han TM, Naicker S, Ramdial PK et al. A cross-sectional study of HIVseropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 2006; 69: 2243-2250.
45. Fabian J, Naicker S. HIV and kidney disease in sub-Saharan Africa. Nat Rev Nephrol 2009; 5: 591-598.
46. Gerntholtz TE, Goetsch SJ, Katz I. HIV-related nephropathy: a South African perspective. Kidney Int 2006; 69: 1885-1891.
47. Wearne N, Swanepoel CR, Boulle A et al. The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations. Nephrol, Dial, Transplant 2012; 27: 4109-4118.
48. Kimmel PL, Phillips TM, Ferreira-Centeno A et al. HIV-associated immunemediated renal disease. Kidney Int 1993; 44: 1327-1340.
49. Behar DM, Kedem E, Rosset S et al. Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population. Am J Nephrol 2011; 34: 452-459.
50. Kalayjian RC, Franceschini N, Gupta SK et al. Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS 2008; 22: 481-487.